Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 2.530
+0.030 (1.20%)
At close: Apr 30, 2026
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €110.47 million as of May 1, 2026. Its market cap has decreased by -45.34% in one year.
Market Cap
110.47M
Enterprise Value
104.54M
Revenue
10.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.53
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 110.47M, a decrease of -73.56%. That is a compound annual growth rate of -21.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 110.47M | -37.15% |
| Dec 31, 2025 | 175.76M | -43.15% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.01B |
| argenx SE | 41.54B |
| Financière de Tubize | 8.71B |
| Fagron NV | 1.76B |
| Ion Beam Applications | 390.28M |
| Onward Medical | 184.95M |
| Hyloris Pharmaceuticals | 135.80M |
| Sequana Medical NV | 43.56M |